The Dream Wars: How Modern Medicine Suppresses Consciousness and Fuels Violence

From REM Suppression to Cognitive Collapse—The Hidden Crisis of Psychiatric Medication

Executive Summary

• Modern society faces an unprecedented dual crisis: widespread REM sleep suppression creating spiritual and psychological damage, while the very medications prescribed to "help" are accelerating cognitive decline, violence, and death.

• SSRIs and related antidepressants not only suppress dreams and REM sleep but have now been linked in major studies to faster dementia progression, increased fractures, higher mortality, and in rare cases, homicidal violence—particularly in the first weeks of treatment.

• The pineal gland, historically considered the "seat of the soul," accumulates industrial toxins at levels up to 21,000 mg/kg, while psychiatric medications further assault this critical organ through disruption of melatonin, serotonin, and potentially endogenous DMT production.

• Breaking research reveals SSRIs impair eye movements, creating visual instability and dissociation that may contribute to violent episodes, while courts worldwide increasingly recognize "antidepressant-induced violence" as grounds for diminished responsibility.

• Natural alternatives like saffron, omega-3s, and exercise have been proven equally or more effective than SSRIs without the devastating side effects, yet remain marginalized by a medical system built on the discredited "chemical imbalance" theory of depression.

The Silent Epidemic of Dream Deprivation

Modern life has fostered a "wake-centric" culture that devalues dreaming and inadvertently suppresses the REM (Rapid Eye Movement) sleep in which most dreaming occurs. REM sleep is not merely a nightly neurological curiosity; it plays essential roles in memory consolidation, emotional processing, creativity, and even immune function. Yet millions of people today experience reduced or fragmented REM sleep—an invisible form of sleep deprivation that specifically targets the dream state.

Common culprits include medications, substances, and lifestyle factors. Many widely used antidepressants, anti-anxiety drugs, antihistamines, opioids, and even nightly alcohol or cannabis use are known to disrupt or blunt REM/dreaming. Research finds that the use of such substances is so pervasive that an epidemic of "REM/dream loss" is unfolding silently. Sleep disorders like insomnia and apnea further compound this, as disrupted sleep naturally means disrupted dreaming. The consequence is that a large segment of society is chronically starved of dreams.

Such REM suppression has tangible neuropsychological effects. Clinically, loss of dreaming is linked to mood dysregulation, memory problems, and impaired learning. Notably, disrupted or deficient REM sleep correlates with higher risks of depression and anxiety. Some researchers have even described depression as "a loss of one's dreams," noting that depressed patients often show REM patterns resembling those of experimentally REM-deprived subjects. Physically, compromised REM/dreaming is associated with weakened immunity, higher inflammation, and even increased risk of neurodegenerative disease. When our dream life is shut down, our mind and body both suffer.

The Pharmaceutical Assault on Dreams

The modern epidemic of dream suppression cannot be separated from the pharmaceutical revolution of the past half-century. In 1943, Swiss chemist Albert Hofmann discovered LSD's mind-bending effects, inadvertently launching the era of serotonergic drug research. By 1954, researchers noticed LSD's molecular structure closely resembled serotonin, hypothesizing that mental illness might stem from neurotransmitter imbalances. This revelation catalyzed a scientific revolution, with researchers racing to develop drugs that could modulate serotonin to treat psychiatric disorders.

Parallel to these academic discoveries, the CIA's Project MKUltra covertly dosed unwitting subjects with LSD and other psychotropic drugs in the 1950s and 60s, attempting to develop mind-control techniques. These illegal experiments, conducted at over 80 institutions, blurred the line between defense research and mainstream psychiatry. While the CIA sought a "truth serum," mainstream researchers sought to heal minds—but both converged on the serotonergic system as key.

By the late 1980s, the first SSRI, fluoxetine (Prozac), was introduced, explicitly designed to "selectively" increase serotonin levels. As Dr. David Nichols notes, "Drugs that affect the serotonin system such as fluoxetine (Prozac)...were certainly developed more quickly because of the discovery of LSD."

The SSRIs promised to relieve depression with fewer side effects than previous drugs. Today, roughly 1 in 8 Americans over age 12 takes an antidepressant.

When Dreams Turn to Nightmares—The Violence Connection

REM Suppression and Emotional Disintegration

Every night during REM sleep, our brains enter a bizarre theater of dreams. Muscles go limp (atonia) to prevent us from acting out dreams, while emotional centers light up, processing the day's memories, fears, and desires. REM sleep plays a crucial role in emotional integration, memory consolidation, fear extinction, and even moral decision-making. Neuroscientists have found that REM-rich sleep after trauma helps the brain extinguish fearful associations, and that dreaming of distressing events can be a form of overnight therapy—what one researcher called a "nocturnal emotional curator."

SSRIs profoundly disrupt this process. These drugs suppress and fragment REM sleep, causing fewer minutes of REM, delayed onset, and frequent awakenings. Perhaps most disturbingly, SSRIs often cause REM sleep without atonia—meaning the body's paralysis fails and people physically act out their dreams. A 2024 Cleveland Clinic study found that SSRI users had 4.1% more REM sleep epochs without atonia compared to non-users, and those on certain antidepressant combinations had up to 18.7% of their REM sleep without paralysis.

The SSRI Dementia Bombshell

In June 2025, a groundbreaking Swedish national cohort study dropped like a bombshell on the psychiatric establishment. As reported in "SSRI Shockwave: New Study Ties Antidepressants to Faster Cognitive Decline, Fractures, and Early Death", this massive investigation—one of the largest and most methodologically rigorous of its kind—found devastating associations between SSRI use and accelerated dementia:

• Escitalopram was linked with the steepest annual cognitive decline (-0.76 MMSE points/year)

• Higher SSRI doses increased risk of severe dementia by 35%

• Fracture risk increased by 25%

• Mortality risk increased by 18%

The study's authors noted these effects persisted even after controlling for depression severity, suggesting the drugs themselves—not the underlying condition—drive the cognitive deterioration. Even more damning, the research revealed SSRIs exhibit direct neurotoxic effects, including:

• Disruption of neurogenesis and neuroplasticity

• Damage to mitochondrial function

• Suppression of melatonin production

• Calcification of the pineal gland, particularly with fluorinated compounds like fluoxetine (Prozac)

As we previously reported: "How can a drug that impairs your pineal gland—the endocrine seat of your circadian, hormonal, and arguably spiritual coherence—be considered therapeutic?"

The Windows to the Soul: How SSRIs Hijack Eye Movement

One of the most underreported yet profoundly disturbing effects of SSRIs is their impact on eye movement and visual processing. The eyes, often called "windows to the soul," are not merely passive cameras but active neurological instruments intimately connected to our emotional and cognitive states.

Saccadic dysfunction is increasingly recognized in SSRI users. Research shows that SSRIs significantly slow saccadic velocity and increase saccadic latency—the eyes move more sluggishly and take longer to initiate movements. Patients on fluoxetine (Prozac) showed up to 20% reduction in peak saccadic velocity. This isn't minor; saccadic movements are fundamental to reading, driving, social interaction, and threat detection.

More alarming is the connection between eye movement abnormalities and violence. Smooth pursuit eye movement (SPEM) deficits—the ability to smoothly track moving objects—have been identified as biomarkers for impulsivity and aggression. SSRIs impair SPEM, creating jerky, unstable visual tracking. When the eyes cannot smoothly track, the brain receives fragmented visual information, potentially contributing to the dissociative states described in SSRI-induced violence.

The pupillary light reflex is also altered by SSRIs, causing prolonged pupil dilation and sluggish responses to light changes. Dilated pupils are associated with fight-or-flight responses, fear, and aggression. When SSRIs chronically dilate pupils, they may be locking users into a perpetual state of sympathetic arousal—a biological stance primed for conflict.

Perhaps most disturbingly, SSRIs interfere with microsaccades—tiny, unconscious eye movements occurring 1-3 times per second. SSRI users show abnormal microsaccade patterns with increased frequency but decreased amplitude, creating constant visual instability. Some researchers theorize this contributes to the derealization and depersonalization frequently reported by users.

Clinical reports document SSRI-induced oculogyric crisis—involuntary upward eye deviation lasting hours. One case described a 28-year-old woman on Prozac who experienced repeated oculogyric crises accompanied by violent outbursts, with no history of aggression before medication.

Eye contact, fundamental to human empathy, is also affected. Studies show reduced eye contact duration and increased gaze aversion in SSRI users. When eye contact no longer provides emotional feedback, our capacity for empathy may diminish. Avoiding eye contact is one of the most consistent behavioral markers in individuals who commit violent crimes.

Akathisia: Inner Agitation Unleashed

If REM deprivation is a subtle destabilizer, akathisia is a more acute culprit behind antidepressant-induced violence. Akathisia is characterized by unbearable inner restlessness—sufferers feel like they "want to jump out of [their] skin" and cannot sit still. It's often described as torture-like dysphoria. SSRIs and SNRIs cause akathisia in an estimated 5-10% of patients.

Clinicians have long observed that akathisia can precipitate suicidal or violent urges in patients who previously had none. A landmark 2011 paper by Dr. Yolande Lucire examined 10 cases of individuals who committed or attempted homicide while on antidepressants experiencing akathisia. All had no prior violence history. Genetic testing revealed each had polymorphisms causing impaired drug metabolism, leading to toxic buildup and severe akathisia. Every one returned to normal after medication withdrawal.

Case Files: When Medicine Becomes Murder

The true test of the SSRI-violence hypothesis lies in the mounting case data:

• Donald Schell (Wyoming, 1998) – 46 hours on Paxil. No violence history. On his second day, he became acutely agitated, said the medication was "making his head crazy," then murdered his family. Jury held drug 80% responsible.

• Deirdre Morley (Dublin, 2020) – Pediatric nurse on five different antidepressants. Became psychotic and smothered her three children, believing she was "saving" them. Found not guilty by reason of insanity.

• Mary Baymiller (Nevada, 2011) – 72-year-old on Paxil plus benzodiazepines. Developed extreme agitation, then stabbed husband 200+ times. Court ruled medications directly caused her actions.

• School Shooters – Eric Harris (Columbine) was on Luvox. Jeff Weise (Red Lake) on Prozac. Countless others with SSRI connections, often showing worsening behavior shortly after medication changes.

What connects these cases? The violence is impulsive, out-of-character, often occurring soon after medication changes, with perpetrators showing warning signs like insomnia, agitation, or personality changes.

The Spiritual and Neurological Battleground

The Pineal Gland Under Siege

The pineal gland, that tiny pine-cone-shaped organ deep in the brain, has long fascinated both scientists and mystics. René Descartes called it the "principal seat of the soul," the point where mind and body meet. Modern research is uncovering why this ancient intuition may have been prescient.

The pineal produces melatonin, regulating circadian rhythms and REM sleep timing. But it may do much more. Researchers like Dr. Rick Strassman theorize the pineal might produce endogenous DMT during REM sleep, birth, death, and mystical experiences. The gland produces beta-carbolines chemically similar to compounds in ayahuasca. Terence McKenna suggested we might be "dressing up in the mental furniture of the distant future" through these natural psychedelics during dreams.

Alarmingly, the pineal gland accumulates environmental toxins. Studies show the human pineal can become the most fluoride-saturated organ in the body, with autopsy studies finding levels up to 21,000 mg/kg in calcified deposits. This calcification correlates with reduced melatonin and sleep disturbances. Combined with SSRI-induced disruption, we may be witnessing a dual chemical assault on the "third eye."

Consciousness as Quantum Antenna

Beyond orthodox science lie provocative theories about consciousness itself. Some researchers propose the brain operates as a "scalar interferometer"—a quantum antenna transmitting and receiving information through subtle fields. During REM sleep and meditation, brainwaves exhibit coherence patterns that some link to "shamanic consciousness" or non-local information processing.

If dreaming is when the brain's antenna tunes beyond the individual—accessing collective unconscious or spiritual dimensions—then suppressing REM essentially jams the signal. By flooding society with dream-suppressing factors (psychiatric meds, blue-light screens, fluoride), humanity's innate ability to access expanded consciousness may be systematically curtailed.

The Shamanic Perspective

Across indigenous cultures, dreams were revered as portals to the spirit world. Shamans used lucid dreaming as technology for accessing spiritual power and wisdom. Australian Aboriginals speak of "Dreamtime" as fundamental reality. Tibetan Buddhists developed "Dream Yoga" for spiritual growth.

From this perspective, our cultural loss of dreaming represents a loss of vision. Chronic dream deprivation leaves us "dispirited"—cut off from nature's voices and unconscious guidance. As one shaman observed: "A society that ignores its dreams has lost its soul."

Carl Jung understood this deeply, calling dreams "essential communications from the unconscious." He warned that Western dismissal of dreams was dangerous arrogance. In Jung's view, widespread REM suppression represents a literal "soul crisis"—society cut off from unconscious wisdom, prone to materialism and spiritual emptiness.

The Path Forward—Reclaiming Our Nights and Minds

Regulatory Awakening and Legal Recognition

The tide is slowly turning. In 2025, U.S. Health Secretary Robert F. Kennedy Jr. announced the government is "launching studies on the potential contribution of SSRI drugs to violence." Japan's Ministry of Health issued warnings that acts of violence can not be ruled out as causally linked to SSRI’s:

“There are cases where we cannot rule out a causal relationship [of hostility, anxiety, and sudden acts of violence] with the medication.” [Source]

Courts increasingly recognize "antidepressant-induced violence" as grounds for diminished responsibility.

FDA has quietly updated certain labels to mention "aggression" and "violent behavior," though these warnings remain buried deep in documentation. The Swedish dementia study adds urgency to calls for reform—we're not just dealing with rare violence cases but systematic cognitive destruction.

Natural Alternatives That Actually Work

The tragedy deepens when we realize effective, safe alternatives exist:

Saffron Extract – Multiple studies show saffron matches or exceeds SSRI effectiveness for depression, with dramatically better safety profiles. No REM suppression, no violence, no dementia acceleration.

Exercise – A 2023 BMJ meta-analysis found exercise interventions are as effective as antidepressants for mild-moderate depression, with zero neurotoxic effects. Exercise actually enhances REM sleep and cognitive function.

Omega-3 Fatty Acids – High-EPA omega-3s significantly improve depression scores with effect sizes comparable to medication. They're neuroprotective rather than neurotoxic.

Psychotherapy – Cognitive Behavioral Therapy rivals medication effectiveness while teaching actual coping skills rather than chemically suppressing symptoms.

Other Options – St. John's Wort, SAM-e, probiotics, light therapy, meditation—all show efficacy without dream suppression or violence risk. View the extensive GreenMedInfo.com database on close to 400 different natural approaches to depression here.

Practical Steps for Protection

For those currently on SSRIs or considering them:

1. Genetic Testing – CYP450 enzyme testing can identify poor metabolizers at risk for toxic accumulation

2. Intense Early Monitoring – The first 4-8 weeks are critical; watch for agitation, insomnia, personality changes

3. Informed Consent – Demand full disclosure about violence, dementia, and cognitive risks—not just suicide warnings

4. Gradual Transitions – Never stop SSRIs abruptly; withdrawal can trigger its own violence/psychosis. Use Inner Compass Initiatives as a resource to go off of SSRIs safely.

5. Document Everything – Keep detailed logs of medication changes and behavioral shifts

The Deeper Questions

The Chemical Imbalance Lie

For decades, depression was marketed as a "chemical imbalance" requiring chemical correction. This monoamine hypothesis—now quietly disowned even by mainstream psychiatry—has generated billions in revenue while potentially damaging millions of brains. There is no convincing evidence that serotonin deficiency causes depression. The theory is not just flawed; it's intellectually bankrupt.

Yet it continues serving as justification for mass medication, even as evidence mounts that these drugs may be causing the very imbalances they claim to correct—disrupting REM sleep, calcifying pineal glands, accelerating neurodegeneration.

A Society at War with Its Own Consciousness

Step back and observe the larger pattern: A society that systematically suppresses dreams through medication, lifestyle, and environmental toxins. A medical system that responds to emotional distress by chemically lobotomizing the dream function. Courts filling with cases of medication-induced violence. Nursing homes filled with drug-accelerated dementia.

Is this healing? Or have we created a kind of psychospiritual warfare against our own population—keeping people perpetually awake yet never truly conscious, medicated yet never truly well?

Conclusion: The Choice Before Us

We stand at a crossroads. Down one path lies continued outsourcing of our emotional and cognitive health to chemical interventions based on discredited theories—accepting violence, dementia, and dream death as "side effects." Down the other lies recognition that dreams are not optional—they are fundamental to human consciousness, creativity, and sanity.

The evidence is now overwhelming: SSRIs and related drugs don't just fail to heal; they actively harm. They suppress the dreams that process trauma, destroy the eye movements that ground us in reality, accelerate the dementia they claim to prevent, and in some cases, transform peaceful people into killers.

Yet natural alternatives exist—proven, safe, accessible. Exercise that enhances rather than suppresses dreams. Saffron that lifts mood without lifting violence risk. Therapies that build resilience rather than chemical dependence.

The war against dreams is ultimately a war against human consciousness itself. Each of us must decide: Will we reclaim our nights and with them our sanity? Or will we continue accepting a medicated twilight that dims both our dreams and our humanity?

The pineal gland—Descartes' "seat of the soul"—may be under chemical siege, but it still flickers within us. The question is whether we'll clear away the pharmaceutical fog long enough to let it shine again, illuminating the path back to authentic healing and genuine wholeness.

As we restore the dark, quiet nights needed for dreaming, we don't just heal ourselves. We reclaim a birthright of humanity—the capacity to journey nightly into inner infinity, to receive wisdom from beyond the veil of waking, and to remember that we are more than mere cogs in a medical-industrial machine.

The dreams are calling us home. The only question is: Will we answer?

Learn more about the profound yet underreported harms associated with SSRIs below:

References

Primary Sources:

1. Mo, M., et al. "Antidepressant use and cognitive decline in patients with dementia: a national cohort study." BMC Medicine, 2025. https://doi.org/10.1186/s12916-025-03851-3

2. Naiman, Rubin. "In exile from the dreamscape: We live in a wake-centric world that devalues dreaming." Aeon, 2020.

3. Molero et al. "SSRIs and Violent Crime: A Cohort Study." PLOS Medicine, 2015.

4. "Certain Antidepressants Increase REM Sleep Without Atonia." Cleveland Clinic Consult QD, 2024.

5. Lucire & Crotty. "Antidepressant-induced akathisia and homicide." Journal of Forensic Psychiatry, 2011.

   Additional Resources:

6. Jung, Carl G. Collected Works, "The Meaning of Psychology for Modern Man," 1933.

7. McKenna, Terence. "The Birth of a New Humanity." 1991.

8. Grof, Stanislav. "Observations from LSD Psychotherapy." Journal of Transpersonal Psychology, 1972.

9. Chlubek, D., et al. "Fluoride and the Pineal Gland." Applied Sciences, 2020.

10. Singh & Gobrogge. "Neural circuits of aggression." Brain Sciences, 2024.

11. Natural Alternatives Research:

12. Noetel et al. "Effect of exercise for depression: systematic review and network meta-analysis." BMJ, 2024.

13. Shafiee et al. "Effect of Saffron vs. SSRIs in Depression: Meta-analysis of RCTs." Nutritional Neuroscience, 2025.

14. Liao et al. "Efficacy of omega-3 PUFAs in depression: Meta-analysis." Translational Psychiatry, 2019.

15. Zhang et al. "Effect of prebiotics, probiotics, synbiotics on depression." BMC Psychiatry, 2023.